F. Cognetti

6.8k total citations · 1 hit paper
129 papers, 4.8k citations indexed

About

F. Cognetti is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, F. Cognetti has authored 129 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 81 papers in Oncology, 51 papers in Pulmonary and Respiratory Medicine and 33 papers in Cancer Research. Recurrent topics in F. Cognetti's work include Cancer Treatment and Pharmacology (42 papers), Colorectal Cancer Treatments and Studies (22 papers) and Lung Cancer Treatments and Mutations (19 papers). F. Cognetti is often cited by papers focused on Cancer Treatment and Pharmacology (42 papers), Colorectal Cancer Treatments and Studies (22 papers) and Lung Cancer Treatments and Mutations (19 papers). F. Cognetti collaborates with scholars based in Italy, United States and India. F. Cognetti's co-authors include M. van Glabbeke, M. Bolla, C. Domenge, Jean-Louis Lefèbvre, Katarzyna Łukawska‐Matuszewska, Mahmut Özsahin, P. Maingon, Richard Greiner, J. Giralt and Jacques Bernier and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Cancer.

In The Last Decade

F. Cognetti

125 papers receiving 4.7k citations

Hit Papers

Postoperative Irradiation... 2004 2026 2011 2018 2004 500 1000 1.5k 2.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Postoperative Irradiation with or without Concomitant Chemotherapy for Locally Advanced Head and Neck Cancer
    2004 2.2k citations Jacques Bernier, C. Domenge et al. New England Journal of Medicine profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
F. Cognetti 2.3k 2.2k 1.9k 1.3k 933 129 4.8k
Éva Remenár 2.7k 1.2× 2.9k 1.3× 1.8k 1.0× 2.0k 1.5× 1.1k 1.2× 64 5.0k
Jan B. Vermorken 2.2k 0.9× 2.1k 0.9× 2.3k 1.2× 1.6k 1.2× 731 0.8× 96 5.6k
Jan B. Vermorken 3.1k 1.4× 2.2k 1.0× 1.4k 0.7× 2.1k 1.6× 1.3k 1.4× 45 5.6k
Roger Ove 2.0k 0.9× 1.7k 0.8× 1.1k 0.6× 1.7k 1.3× 978 1.0× 36 4.1k
D. De Raucourt 2.2k 0.9× 2.8k 1.3× 1.9k 1.0× 1.9k 1.4× 787 0.8× 55 4.4k
Armin Schueler 2.2k 1.0× 1.8k 0.8× 962 0.5× 1.6k 1.2× 962 1.0× 18 3.8k
Scott Saxman 2.5k 1.1× 2.2k 1.0× 2.4k 1.2× 1.5k 1.1× 1.2k 1.3× 41 5.5k
Daniel T. T. Chua 2.8k 1.2× 4.6k 2.1× 3.5k 1.8× 2.0k 1.5× 555 0.6× 96 6.2k
Marco Merlano 2.2k 1.0× 1.3k 0.6× 848 0.4× 1.4k 1.0× 1.3k 1.4× 188 4.6k
Ranjan Sur 3.0k 1.3× 2.6k 1.2× 2.2k 1.1× 3.0k 2.2× 1.3k 1.4× 68 6.4k

Countries citing papers authored by F. Cognetti

Since Specialization
Citations

This map shows the geographic impact of F. Cognetti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Cognetti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Cognetti more than expected).

Fields of papers citing papers by F. Cognetti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Cognetti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Cognetti. The network helps show where F. Cognetti may publish in the future.

Co-authorship network of co-authors of F. Cognetti

This figure shows the co-authorship network connecting the top 25 collaborators of F. Cognetti. A scholar is included among the top collaborators of F. Cognetti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Cognetti. F. Cognetti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fabi, Alessandra, G. Ferretti, Paola Malaguti, et al.. (2020). Nanoparticle Albumin-Bound Paclitaxel/Liposomal-Encapsulated Doxorubicin in HER2-Negative Metastatic Breast Cancer Patients. Future Oncology. 16(22). 1631–1639. 10 indexed citations
2.
3.
Merola, Roberta, Marcella Mottolese, F. Cognetti, et al.. (2006). Analysis of aneusomy level and HER-2 gene copy number and their effect on amplification rate in breast cancer specimens read as 2+ in immunohistochemical analysis. European Journal of Cancer. 42(10). 1501–1506. 34 indexed citations
4.
Costanzo, Francesco Di, Silvia Gasperoni, Paola Papaldo, et al.. (2005). Weekly paclitaxel plus capecitabine in advanced breast cancer patients: dose-finding trial of GOIRC and GOL. Annals of Oncology. 17(1). 79–84. 11 indexed citations
5.
Russell‐Edu, William, et al.. (2005). More information, more choice: an Italian database for oncology patients. Annals of Oncology. 16(12). 1962–1967. 2 indexed citations
6.
Nisticò, Cecilia, F. Cognetti, Luciano Frontini, et al.. (2005). Weekly Docetaxel in Pretreated Metastatic Breast Cancer Patients: A Phase I-II Study. Oncology. 68(4-6). 356–363. 9 indexed citations
7.
Gelibter, Alain, Anna Ceribelli, Michèle Milella, et al.. (2005). Impact of gefitinib (‘Iressa’) treatment on the quality of life of patients with advanced non-small-cell lung cancer. Journal of Cancer Research and Clinical Oncology. 131(12). 783–788. 7 indexed citations
8.
Garufi, Carlo, Emilio Bria, Cecilia Nisticò, et al.. (2005). Randomised phase II study of standard versus chronomodulated CPT-11 plus chronomodulated 5-fluorouracil and folinic acid in advanced colorectal cancer patients. European Journal of Cancer. 42(5). 608–616. 16 indexed citations
9.
Bernier, Jacques, C. Domenge, Mahmut Özsahin, et al.. (2004). Postoperative Irradiation with or without Concomitant Chemotherapy for Locally Advanced Head and Neck Cancer. New England Journal of Medicine. 350(19). 1945–1952. 2209 indexed citations breakdown →
10.
Zeuli, Massimo, Maria Simona Pino, Teresa Gamucci, et al.. (2003). Phase II study of capecitabine and oxaliplatin as first-line treatment in advanced colorectal cancer. Annals of Oncology. 14(9). 1378–1382. 46 indexed citations
11.
Arcangeli, Giorgio, Biancamaria Saracino, Donatella Tirindelli Danesi, et al.. (2002). Accelerated Hyperfractionated Radiotherapy and Concurrent Protracted Venous Infusion Chemotherapy in Locally Advanced Head and Neck Cancer. American Journal of Clinical Oncology. 25(5). 431–437. 4 indexed citations
12.
Serrone, L., Massimo Zeuli, Teresa Gamucci, Marco Nardi, & F. Cognetti. (2001). A phase II study of dose-intense ifosfamide plus epirubicin with hematopoietic growth factors for the treatment of patients with advanced soft tissue sarcomas; a novel sequential schedule. Cancer Chemotherapy and Pharmacology. 47(3). 206–210. 11 indexed citations
13.
Marco, Salvatore De, et al.. (1999). Nephroblastoma in the adult. Medical and Pediatric Oncology. 33(5). 497–499. 2 indexed citations
14.
Verweij, Jaap, P.H.M. de Mulder, Alexander de Graeff, et al.. (1996). Phase II study on mitoxantrone in adenoid cystic carcinomas of the head and neck. Annals of Oncology. 7(8). 867–869. 47 indexed citations
15.
Gridelli, Cesare, S. Palmeri, Modesto DʼAprile, et al.. (1996). Mitomycin C plus vindesine plus etoposide (MEV) versus mitomycin C plus vindesine plus cisplatin (MVP) in stage IV non-small-cell lung cancer: A phase III multicentre randomised trial. Annals of Oncology. 7(8). 821–826. 32 indexed citations
16.
Scinto, Angelo Fedele, et al.. (1995). Accelerated chemotherapy with high-dose epirubicin and cyclophosphamide plus r-met-HUG-CSF in locally advanced and metastatic breast cancer. Annals of Oncology. 6(7). 665–671. 18 indexed citations
17.
18.
Vermorken, J. B., Jaco J. Verweij, F. Cognetti, et al.. (1993). Epirubicin in patients with advanced or recurrent adenoid cystic carcinoma of the head and neck: A phase II study of the EORTC Head and Neck Cancer Cooperative Group. Annals of Oncology. 4(9). 785–788. 69 indexed citations
19.
Cognetti, F., Annalia Molinari, Paolo Carlini, et al.. (1987). Alternating Regimens in Recurrent and Metastatic Squamous Cell Carcinoma of the Head and Neck. Oncology. 44(5). 270–272. 1 indexed citations
20.
Cognetti, F., Paola Pinnarò, & Paolo Carlini. (1984). Combination chemotherapy (CABO) prior to radiation for locally advanced inoperable squamous cell carcinoma of the head and neck. Journal of Experimental & Clinical Cancer Research. 3(3). 271–275. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Éva Remenár Breakdown of academic impact, for papers by Jan B. Vermorken Breakdown of academic impact, for papers by Jan B. Vermorken Breakdown of academic impact, for papers by Roger Ove Breakdown of academic impact, for papers by D. De Raucourt Breakdown of academic impact, for papers by Armin Schueler Breakdown of academic impact, for papers by Scott Saxman Breakdown of academic impact, for papers by Daniel T. T. Chua Breakdown of academic impact, for papers by Marco Merlano Breakdown of academic impact, for papers by Ranjan Sur
Rankless by CCL
2026